The Greater Cannabis Company, Inc. Logo

The Greater Cannabis Company, Inc.

GCAN

(1.8)
Stock Price

0,00 USD

-236.34% ROA

25.05% ROE

-2.12x PER

Market Cap.

402.319,00 USD

-57.47% DER

0% Yield

0% NPM

The Greater Cannabis Company, Inc. Stock Analysis

The Greater Cannabis Company, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

The Greater Cannabis Company, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (51.65%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (-1.04x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a minimal amount of debt (-80%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

5 ROA

The stock's ROA (-124.82%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

The Greater Cannabis Company, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

The Greater Cannabis Company, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

The Greater Cannabis Company, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

The Greater Cannabis Company, Inc. Revenue
Year Revenue Growth
2015 0
2016 0 0%
2017 209 100%
2018 95.375 99.78%
2019 7.120 -1239.54%
2020 48.044 85.18%
2021 12.630 -280.4%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

The Greater Cannabis Company, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

The Greater Cannabis Company, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 210
2016 0 0%
2017 646.220 100%
2018 235.593 -174.3%
2019 204.000 -15.49%
2020 204.000 0%
2021 151.000 -35.1%
2022 120.000 -25.83%
2023 120.000 0%
2023 0 0%
2024 120.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

The Greater Cannabis Company, Inc. EBITDA
Year EBITDA Growth
2015 -6.210
2016 -100.000 93.79%
2017 -646.120 84.52%
2018 -767.520 15.82%
2019 -755.599 -1.58%
2020 -1.059.308 28.67%
2021 -717.580 -47.62%
2022 -232.535 -208.59%
2023 -196.860 -18.12%
2023 -170.364 -15.55%
2024 -152.040 -12.05%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

The Greater Cannabis Company, Inc. Gross Profit
Year Gross Profit Growth
2015 0
2016 0 0%
2017 100 100%
2018 0 0%
2019 -46.005 100%
2020 -46 -99910.87%
2021 -25 -84%
2022 -52.035 99.95%
2023 -76.860 32.3%
2023 -5.000 -1437.2%
2024 -5.000 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

The Greater Cannabis Company, Inc. Net Profit
Year Net Profit Growth
2015 -3.210
2016 -103.000 96.88%
2017 -793.567 87.02%
2018 -839.070 5.42%
2019 -2.147.861 60.93%
2020 -2.578.709 16.71%
2021 -509.809 -405.82%
2022 -543.501 6.2%
2023 -213.720 -154.31%
2023 -188.402 -13.44%
2024 -179.668 -4.86%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

The Greater Cannabis Company, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

The Greater Cannabis Company, Inc. Free Cashflow
Year Free Cashflow Growth
2015 -210
2016 0 0%
2017 4.670 100%
2018 -100.109 104.66%
2019 -285.229 64.9%
2020 -314.627 9.34%
2021 -235.433 -33.64%
2022 -107.490 -119.03%
2023 -103.171 -4.19%
2023 -41.215 -150.32%
2024 -37.536 -9.8%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

The Greater Cannabis Company, Inc. Operating Cashflow
Year Operating Cashflow Growth
2015 -210
2016 0 0%
2017 4.670 100%
2018 -100.109 104.66%
2019 -285.229 64.9%
2020 -289.627 1.52%
2021 -235.433 -23.02%
2022 -107.490 -119.03%
2023 -103.171 -4.19%
2023 -41.215 -150.32%
2024 -37.536 -9.8%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

The Greater Cannabis Company, Inc. Capital Expenditure
Year Capital Expenditure Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 25.000 100%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

The Greater Cannabis Company, Inc. Equity
Year Equity Growth
2015 -5.790
2016 -108.788 94.68%
2017 -376.980 71.14%
2018 -563.786 33.13%
2019 -1.546.634 63.55%
2020 -279.788 -452.79%
2021 -469.062 40.35%
2022 -544.830 13.91%
2023 -661.232 17.6%
2023 -650.371 -1.67%
2024 -750.760 13.37%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

The Greater Cannabis Company, Inc. Assets
Year Assets Growth
2015 100.000
2016 0 0%
2017 993 100%
2018 149.640 99.34%
2019 52.662 -184.15%
2020 180.120 70.76%
2021 392.937 54.16%
2022 280.447 -40.11%
2023 172.276 -62.79%
2023 206.199 16.45%
2024 83.233 -147.74%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

The Greater Cannabis Company, Inc. Liabilities
Year Liabilities Growth
2015 105.790
2016 108.788 2.76%
2017 377.973 71.22%
2018 713.426 47.02%
2019 1.599.296 55.39%
2020 459.908 -247.74%
2021 861.999 46.65%
2022 825.277 -4.45%
2023 833.508 0.99%
2023 856.570 2.69%
2024 833.993 -2.71%

The Greater Cannabis Company, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-2.12x
Price To Sales Ratio
0x
POCF Ratio
-3.29
PFCF Ratio
-3.29
Price to Book Ratio
-0.54
EV to Sales
0
EV Over EBITDA
-4.49
EV to Operating CashFlow
-6.16
EV to FreeCashFlow
-6.16
Earnings Yield
-0.47
FreeCashFlow Yield
-0.3
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.64
ROE
0.27
Return On Assets
-2.85
Return On Capital Employed
0.2
Net Income per EBT
1
EBT Per Ebit
1.12
Ebit per Revenue
0
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.53
Return on Tangible Assets
-2.36
Days Sales Outstanding
0
Days Payables Outstanding
83.59
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
4.37
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-0.57
Debt to Assets
5.18
Net Debt to EBITDA
-2.09
Current Ratio
0.1
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-750760
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.04
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
1.07

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

The Greater Cannabis Company, Inc. Dividends
Year Dividends Growth

The Greater Cannabis Company, Inc. Profile

About The Greater Cannabis Company, Inc.

The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.

CEO
Mr. Aitan Zacharin
Employee
1
Address
15 Walker Avenue
Baltimore, 21208

The Greater Cannabis Company, Inc. Executives & BODs

The Greater Cannabis Company, Inc. Executives & BODs
# Name Age
1 Motti Stenge
Chief Operating Officer
70
2 Mr. Aitan Zacharin
Chairman, President, Chief Executive Officer, Acting Chief Financial Officer & Treasurer
70
3 Dr. Adi Aran M.D.
Chief Scientific Advisor
70

The Greater Cannabis Company, Inc. Competitors